Clearwater

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease1 trial
• Macular degeneration1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• EyePoint Pharmaceuticals, Inc.2 trials

Closed trials

• Completed

  Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

  NCT05383209· Phase 2· EyePoint Pharmaceuticals, Inc.· Source

• Completed

  Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

  NCT05381948· Phase 2· EyePoint Pharmaceuticals, Inc.· Source